Individual prediction in prostate cancer studies using a joint longitudinal survival-cure model

Journal of the American Statistical Association

Volumn 103, Issue 481, 2008, Pages 178-187

  Yu, Menggang ^a   Taylor, Jeremy M G ^b   Sandler, Howard M ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cure models; Joint model; Longitudinal model; Markov chain Monte Carlo; Prostate cancer data; Survival model

Indexed keywords

EID: 42349110012     PISSN: 01621459     EISSN: None     Source Type: Journal    
DOI: 10.1198/016214507000000400     Document Type: Article

References (41)

1. Bagdonavicius, V, and Nikulin, M. (2001 ), Accelerated Life Models: Modeling and Statistical Analysis, London: Chapman & Hall.
2. Brown, E. R., and Ibrahim, J. G. (2003), "Bayesian Approaches to Joint Cure-Rate and Longitudinal Models With Application to Cancer Vaccine Trials," Biometrics, 59, 686-693.
3. Bycott, P., and Taylor, J. M. G. (1998), "A Comparison of Smoothing Techniques for CD4 Data Measured With Error in a Time-Dependent Cox Proportional Hazards Model," Statistics in Medicine, 17, 2061-2077.
4. Casella, G., and George, E. I. (1992), "Explaining the Gibbs Sampler," The American Statistician, 46, 167-174.
5. Chen, M. H., Ibrahim, J. G., and Sinha, D. (1999), "A New Bayesian Model for Survival Data With a Survival Fraction," Journal of the American Statistical Association, 94, 909-919.
6. _ (2004), "A New Joint Model for Longitudinal and Survival Data With a Cure Fraction," Journal of Multivariate Analysis, 91, 18-34.
7. Chib, S. (1995), "Marginal Likelihood From the Gibbs Output," Journal of the American Statistical Association, 90, 1313-21.
8. Chib, S., and Jeliazkov, I. (2004), "Marginal Likelihood From the Metropolis-Hastings Output," Journal of the American Statistical Association, 96, 270-281.
9. Farewell, V. T. ( 1982), "The Use of Mixture Models for the Analysis of Survival Data With Long-Term Survivors," Biometrics, 38, 1041-1046.
10. _ (1986), "Mixture Models in Survival Analysis: Are They Worth the Risk?" The Canadian Journal of Statistics, 14, 257-262.
11. Faucett, C. L., and Thomas, D. C. (1996), "Simultaneously Modeling Censored Survival Data and Repeatedly Measured Covariates: A Gibbs Sampling Approach," Statistics in Medicine, 15, 1663-1685.
12. Geisser, S., and Eddy, W. (1979), "A Predictive Approach to Model Selection," Journal of the American Statistical Association, 74, 153-160.
13. Gelfand, A. E. (1995), "Model Determination Using Sampling-Based Methods," in Markov Chain Monte Carlo in Practice, eds. W. R. Gilds, S. Richardson, and D. J. Spiegelhalter, London: Chapman & Hall, pp. 145-161.
14. Gelfand, A. E., Dey, D. K., and Chang, H. (1992), "Model Determination Using Predictive Distributions With Implementation via Sampling-Based Methods," in Bayesian Statistics 4, eds, J. M. Bernardo, J. O. Berger, A. P. Dawid, and A. F. M. Smith, Oxford, U.K.: Oxford University Press, pp. 147-167.
15. Gelman, A., and Rubin, D. B. (1992), "Inference From Iterative Simulation Using Multiple Sequences," Statistical Science, 7, 457-472.
16. Gilks, W., and Wild, P. (1992), "Adaptive Rejection Sampling for Gibbs Sampling," Applied Statistics, 41, 337-348.
17. Henderson, R., Diggle, P., and Dobson, A. (2000), "Joint Modeling of Longitudinal Measurements and Event Time Data," Biostatistics, 1, 465-480.
18. Kalbfleisch, J. D., and Prentice, R. L. (2002), The Statistical Analysis of Failure Time Data (2nd ed.), New Jersey: Wiley.
19. Kuk, A. Y. C., and Chen, C. H. (1992), "A Mixture Model Combining Logistic Regression With Proportional Hazards Regression," Biometrika, 79, 531-541.
20. Lange, K., Little, R. J. A., and Taylor, J. M. G. (1989), "Robust Statistical Modeling Using the t Distribution," Journal of the American Statistical Association, 84, 881-896.
21. Law, N. J., Taylor, J. M. G., and Sandler, H. (2002), "The Joint Modeling of a Longitudinal Disease Progression Marker and the Failure Time Process in the Presence of Cure," Biostatistics, 3, 547-563.
22. Li, C. S., Taylor, J. M. G., and Sy, J. P. (2001), "Identifiability of Cure Models," Statistics and Probability Letters, 54, 389-395.
23. Metropolis, N., Rosenbluth, A. W., Rosenbluth, M. N., Teller, A. H., and Teller, E. (1953), "Equations of State Calculations by Fast Computing Machine," Journal of Chemistry in Physics, 21, 1087-1091.
24. Naylor, J. C., and Smith, A. F. M. (1982), "Applications of a Method for the Efficient Computation of Posterior Distributions," Applied Statistics, 31, 214-255.
25. Pauler, D. K., and Finkelstein, D. M. (2002), "Predicting Time to Prostate Cancer Recurrence Based on Joint Models for Non-Linear Longitudinal Biomark ers and Event Time Outcomes," Statistics in Medicine, 21, 3897-3911.
26. Robins, J. M. (1997), "Structural Nested Failure Time Models," in The Encyclopedia of Biostatistics, eds. P. Armitage and T. Colton, Chichester, U.K.: Wiley, pp. 4372-4389.
27. Sandler, H. M., Dunn, R. L., McLaughlin, P. W., Hayman, J. A., Sullivan, M. A., and Taylor, J. M. G. (2000), "Overall Survival After PSA-Detected Recurrence Following Conformal Radiation Therapy," International Journal of Radiation Oncology, Biology and Physics, 48, 629-633.
28. Sinha, D., and Dey, D. K. (1997), "Semiparametric Bayesian Analysis of Survival Data," Journal of the American Statistical Association, 92, 1195-1211.
29. Skates, S. J., Pauler, D. K., and Jacobs, I. J. (2001), "Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Change-Point Models of Longitudinal Markers," Journal of the American Statistical Association, 96, 429-439.
30. Slate, E. H., and Cronin, K. A. (1997), "Changepoint Modeling of Longitudinal PSA as a Biomarker for Prostate Cancer," in Case Studies in Bayesian Statistics III, New York: Springer-Verlag, pp. 435-456.
31. Song, X., Davidian, M., and Tsiatis, A. A. (2002), "A Semiparametric Likelihood Approach to Joint Modeling of Longitudinal and Time-to-Event Data," Biometrics, 58, 742-753.
32. Taylor, J. M. G. (1995), "Semi-Parametric Estimation in Failure Time Mixture Models," Biometrics, 51, 899-907.
33. Tsiatis, A. A., and Davidian, M. (2004), "An Overview of Joint Modeling of Longitudinal and Time-to-Event Data," Statistica Sinica, 14, 809-834.
34. Tsiatis, A. A., DeGruttola, V., and Wolfsohn, M. S. (1995), "Modeling the Relationship of Survival to Longitudinal Data Measured With Error Applications to Survival and CD4 Counts in Patients With AIDS," Journal of the American Statistical Association, 90, 27-37.
35. Wang, Y., and Taylor, J. M. G. (2001), "Jointly Modeling Longitudinal and Event Time Data With Application to Acquired Immunodeficiency Syndrome," Journal of the American Statistical Association, 96, 895-905.
36. Wulfsohn, M. S., and Tsiatis, A. A. (1997), "A Joint Model for Survival and Longitudinal Data Measured With Error," Biometrics, 53, 330-339.
37. Xu, J., and Zeger, S. L. (2001), "Joint Analysis of Longitudinal Data Comprising Repeated Measures and Times to Events," Applied Statistics, 50, 375-387.
38. Yakovlev, A. Y., and Tsodikov, A. D. (1996), Stochastic Models of Tumor Latency and Their Biostatistical Applications, River Edge, NJ: World Scientific.
39. Yu, M. (2004), "Joint Longitudinal-Survival-Cure Model With Application in Prostate Cancer Studies," unpublished doctoral thesis, University of Michigan.
40. Yu, M., Law, N. J., Taylor, J. M. G., and Sandler, H. M. (2004), "Joint Longitudinal-Survival-Cure Models and Their Application to Prostate Cancer," Statistica Sinica, 14, 809-834.
41. Zagars, G. K., and Pollack, A. (1993), "The Fall and Rise of Prostate-Specific Antigen," Cancer, 72, 832-842.